Compositions and methods for prognosis and treatment of prostate cancer
Described herein are compositions and methods for prognosis and treatment of prostate cancer patients. Specifically the invention relates to microRNA molecules associated with the prognosis of prostate cancer, as well as various nucleic acid molecules relating thereto or derived therefrom.
1. A method for treating a prostate cancer, comprising administering to a subject in need thereof an effective amount of a composition comprising a nucleic acid selected from the group consisting of:
(a) a complementary sequence of SEQ ID NOS: 26 and 59 and
(b) a sequence having at least 80% identity to (a).
2. A method for inhibiting the growth or viability of prostate cancer cells comprising introducing into said cells an effective amount of a nucleic acid selected from the group consisting of (a) a complementary sequence of SEQ ID NOS: 26 and 59; and (b) a sequences having at least 80% identity to (a).